153 related articles for article (PubMed ID: 26004373)
1. WHO includes 16 new cancer drugs on list of essential medicines.
Mayor S
Lancet Oncol; 2015 Jul; 16(7):757. PubMed ID: 26004373
[No Abstract] [Full Text] [Related]
2. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
[TBL] [Abstract][Full Text] [Related]
3. The selection and use of essential medicines.
WHO Expert Committee
World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
[TBL] [Abstract][Full Text] [Related]
4. WHO Essential Medicines Committee spotlights unaffordable drugs.
Furlow B
Lancet Oncol; 2021 Nov; 22(11):1503. PubMed ID: 34627500
[No Abstract] [Full Text] [Related]
5. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
[TBL] [Abstract][Full Text] [Related]
6. The selection and use of essential medicines.
World Health Organ Tech Rep Ser; 2004; 920():1-127, back cover. PubMed ID: 15382605
[TBL] [Abstract][Full Text] [Related]
7. The selection and use of essential medicines.
World Health Organization
World Health Organ Tech Rep Ser; 2014; (985):i-xiv, 1-219, back cover. PubMed ID: 25080778
[TBL] [Abstract][Full Text] [Related]
8. Lucentis excluded from WHO list of essential medicines.
Cohen D
BMJ; 2015 May; 350():h2573. PubMed ID: 25971586
[No Abstract] [Full Text] [Related]
9. The selection and use of essential medicines.
World Health Organization
World Health Organ Tech Rep Ser; 2011; (965):i-xiv, 1-249. PubMed ID: 22891532
[TBL] [Abstract][Full Text] [Related]
10. The Selection and Use of Essential Medicines.
World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
[TBL] [Abstract][Full Text] [Related]
11. The selection and use of essential medicines.
WHO Expert Committee
World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
[TBL] [Abstract][Full Text] [Related]
12. New scale assesses benefits of cancer medicines.
Bagcchi S
Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
[No Abstract] [Full Text] [Related]
13. WHO targets antimicrobial resistance in new essential medicines list.
Gulland A
BMJ; 2017 Jun; 357():j2809. PubMed ID: 28600355
[No Abstract] [Full Text] [Related]
14. Essential medicines for the whole world.
Reidenberg MM
Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
[TBL] [Abstract][Full Text] [Related]
15. The use of essential drugs. Eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs).
World Health Organ Tech Rep Ser; 1998; 882():1-77. PubMed ID: 9922706
[TBL] [Abstract][Full Text] [Related]
16. Roche asks WHO to remove Avastin from essential medicines list.
Cohen D
BMJ; 2017 Feb; 356():j779. PubMed ID: 28193603
[No Abstract] [Full Text] [Related]
17. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
Balhara YP
J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
[No Abstract] [Full Text] [Related]
18. Access to essential medicines for children: the world health organization's global response.
Zucker H; Rägo L
Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
[TBL] [Abstract][Full Text] [Related]
19. Expanding medicines for neurologic disorders on the WHO Model List.
Rimmer K; Shah H; Thakur K
Neurology; 2017 Mar; 88(10):e87-e91. PubMed ID: 28265046
[TBL] [Abstract][Full Text] [Related]
20. The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines-Taking Oncology Medicines as an Example.
Cheng L; Li C; Zhang X; Chen Y; Yan J
Front Public Health; 2022; 10():943994. PubMed ID: 35874976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
